Working together to beat the rising threat of drug-resistant infections
AstraZeneca and other key players from across the global biopharmaceutical industry are calling on governments and industry to work together in taking comprehensive action against drug-resistant infections, with a joint declaration launched today at the World Economic Forum in Davos, Switzerland.
Unveiling of 'Science in Pictures' at the Cambridge Biomedical Campus
On Wednesday 13 January, we revealed an artwork installation displayed on the construction hoardings around the Cambridge Biomedical Campus (CBC), the site of our future Research and Development Center and Corporate Headquarters. It depicts the fusion of science and art through the eyes of local Cambridge schoolchildren.
Quick guide to top oncology terminology
New approaches to diagnosing and treating cancer are being discovered and implemented every year. The rapid evolution of terminology and new treatment concepts can be daunting for those not working directly in the medical or research fields. We have compiled a list of cancer terms that patients, advocates, non-medical journalists and others might find useful.
New appointments for Mene Pangalos reflect AstraZeneca’s ongoing commitment to UK science
Yesterday it was announced that Dr Mene Pangalos, Executive Vice President of our IMED Biotech Unit, has accepted two prestigious appointments reflecting AstraZeneca’s long standing commitment to strengthening UK science.
AstraZeneca continues strategic investment in China to accelerate delivery of innovative biologics and targeted medicines
AstraZeneca, along with MedImmune, its global biologics research and development arm, announced a range of strategic initiatives to accelerate the delivery of innovative biologics and targeted medicines to patients in China, the company’s second largest market globally and a key growth platform.
Be among our employees who continue to make us an innovation-driven company that stands firmly among the world’s leaders in biopharmaceuticals.
We partner with others around the world, combining the great science in our labs with complementary technologies, know-how and molecules to accelerate the delivery of new life-changing medicines.
Page Atlas ID: 929087.011
Date of next review: November 2016